Author： Brent Jeffrey
Publisher： Informa Healthcare
ISSN： 1556-3650
Source： Clinical Toxicology, Vol.51, Iss.4, 2013-05, pp. : 195-198
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. :
The diabetic heart - what is to blame and what can we do?
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
Ten years on: what do we know about the Gulf War syndrome?
Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. :